Scilex Holding Company announced that in anticipation of selling our commercially available products to new and current special customers, Scilex has entered into a non-exclusive distribution agreement with a well-known and highly respected distributor with over 10 years of sales excellence, Endeavor Distribution. Endeavor has logistics expertise to sell and distribute our currently marketed non-opioid products nationally.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SCLX:
- Scilex Holding Company Partners with New National Distributor, Endeavor Distribution LLC.
- Scilex Evaluates Strategic Options for Semnur Pharmaceuticals
- Scilex authorizes management to explore ways to maximize value of Semnur
- Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA™) in Lumbosacral Radicular Pain (Sciatica)
- Scilex to present poster on ELYXYB at AHS meeting